What Is Enzyme (MLN) and How Does It Work?
Enzyme (MLN) is a decentralized asset management protocol that lets you create, manage, and invest in
on-chain portfolios using smart contracts. Built originally as Melon Protocol, Enzyme removes traditional fund managers and intermediaries, giving users transparent, non-custodial access to professional-grade portfolio management tools directly on the blockchain.
Enzyme works through vaults, which are smart-contract portfolios that hold assets, execute trades, and follow predefined rules. Vault creators can set parameters such as supported assets, trading strategies, and risk controls, while investors can review performance and allocate capital directly on-chain. All actions, trading, rebalancing, and fee collection, are executed automatically and remain fully auditable.
The MLN token powers the Enzyme ecosystem by covering protocol fees and enabling governance. MLN is used to pay network fees that help maintain the protocol and align incentives, while token holders can participate in governance decisions that shape Enzyme’s future upgrades, integrations, and economic parameters.
When Did Enzyme Finance Launch?
Enzyme originally began its journey as Melon Protocol, a decentralized asset-management project conceived in 2016 by Mona El Isa, a former Goldman Sachs vice-president, and mathematician Rito Trinkler under the Swiss company Melonport AG. The project raised funds through an ICO in February 2017, and after years of development, the mainnet officially launched in 2019. In 2019, Melon Protocol was rebranded to Enzyme Finance as governance transitioned from the original company to a decentralized autonomous organization (DAO) run by the Enzyme Council.
Enzyme Roadmap and Key Milestones
- 2016 – Project founded as Melon Protocol by Mona El Isa and Rito Trinkler.
- Feb 2017 – ICO and token distribution for MLN.
- 2019 – Mainnet launch and rebranding to Enzyme Finance.
- 2021 – V2 upgrade with revised smart contract architecture.
- Feb 2022 – V4 Sulu release with expanded features and multi-chain deployment.
- 2023–2025 – Development of V5, institutional integrations, and ecosystem expansion, e.g., tokenized funds, cross-chain tools.
What Is the MLN Token Utility?
The MLN token is the native utility and governance asset of the Enzyme ecosystem. It is primarily used to pay protocol fees generated by on-chain asset management activities, such as vault operations and fund interactions, with a portion of these fees burned over time to align network usage with token economics. MLN also plays a role in decentralized governance, allowing stakeholders to participate in decisions around protocol upgrades, economic parameters, and long-term development through Enzyme’s DAO-led framework.
You can trade MLN tokens on the
BingX spot market by depositing or buying MLN on BingX and accessing the
MLN/USDT trading pair. BingX provides real-time price charts, flexible order types, and deep liquidity, making it easy to buy or sell MLN as part of your broader crypto portfolio strategy.
What Is Enzyme Finance Tokenomics?
MLN has a fixed maximum supply of 2.66 million tokens, with no ongoing inflation. The token follows a fee-based burn model, where protocol fees generated from Enzyme vault activity are paid in MLN and partially burned, gradually reducing the circulating supply over time. This creates a usage-linked, deflationary pressure tied directly to platform adoption. MLN is also used for governance, enabling token holders to influence protocol upgrades, integrations, and economic parameters through Enzyme’s DAO-led decision-making process.